{"disease":{"id":"excretion","name":"excretion"},"drugs":{"marketed":[{"drug_id":"probenecid","indication_name":"Adjunct Treatment to Inhibit Renal Drug Excretion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Col-Probenecid","generic_name":"probenecid","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 9","drug_class":"probenecid","quality_score":10,"revenue":null,"mechanism":"ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05475223","title":"End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT03204422","title":"Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Population","phase":"","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Beijing Children's Hospital","has_results":false},{"nct_id":"NCT06120608","title":"Evidence for Potassium Restriction in Hemodialysis","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","has_results":false},{"nct_id":"NCT03122561","title":"Estimation of Paracetamol in Urine to Assess the Diurnal Variation","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","has_results":false},{"nct_id":"NCT02908425","title":"Cholesterol and Statin in Healthy Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Texas A&M University","has_results":false},{"nct_id":"NCT05611905","title":"Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06665464","title":"Bioavailability of Omega-3 Fatty Acids From Fish Oil Supplements","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Wageningen University and Research","has_results":false},{"nct_id":"NCT03746821","title":"Biotin Sample Collection Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"SPD Development Company Limited","has_results":false},{"nct_id":"NCT06686004","title":"Bioavailability Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Newcastle University","has_results":false},{"nct_id":"NCT06195319","title":"Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Cassava Sciences, Inc.","has_results":false},{"nct_id":"NCT07537231","title":"A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05238337","title":"A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Pyramid Biosciences","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}